Our results suggested that increased hsa-miR-3178 activates PI3K/Akt signaling pathway, upregulates the expression of ABC transporters and aggravates gemcitabine resistance in pancreatic cancer. The gene discussed is AKT1; the disease is pancreatic neoplasm.